NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

血液檢驗的全球市場: 各產品類型,各技術,疾病的各類型,各終端用戶的市場規模,佔有率 、成長性,需求預測

Blood Screening Market Research Report: By Product Type, Technology, Disease Type, End User - Global Industry Size, Share, Growth and Demand Forecast to 2030

出版商 Prescient & Strategic Intelligence Private Limited 商品編碼 949779
出版日期 內容資訊 英文 328 Pages
商品交期: 2-3個工作天內
價格
血液檢驗的全球市場: 各產品類型,各技術,疾病的各類型,各終端用戶的市場規模,佔有率 、成長性,需求預測 Blood Screening Market Research Report: By Product Type, Technology, Disease Type, End User - Global Industry Size, Share, Growth and Demand Forecast to 2030
出版日期: 2020年04月01日內容資訊: 英文 328 Pages
簡介

全球血液檢驗市場,2019年時有24億230萬美元的規模,從2020年到2030年預計將以8.1%的年複合成長率繼續成長。市場擴大的原動力,是癌症的盛行率上升,器官移植的增加等要素。

本報告提供全球血液檢驗市場調查,世界與各地區市場規模與預測,各產品類型,各技術,疾病的各類型,各終端用戶分析,競爭情形,企業簡介等資訊。

目錄

第1章 背景調查

第2章 調查方法

第3章 摘要整理

第4章 簡介

  • 市場區隔定義
    • 產品類型
    • 各技術
    • 疾病的各類型
    • 各終端用戶
  • 市場動態
    • 趨勢
    • 成長促進因素
    • 成長阻礙因素

第5章 全球市場的規模與預測

  • 各產品類型
    • 試劑和套件
    • 檢驗設備
  • 各技術
    • NAT
    • ELISA
    • 迅速檢驗技術
    • 西方印漬術技術
    • NGS技術
  • 疾病的各類型
  • 各終端用戶
  • 各地區

第6章 北美市場規模與預測

  • 各產品類型
  • 各技術
  • 疾病的各類型
  • 各終端用戶
  • 各國

第7章 歐洲市場規模與預測

  • 各產品類型
  • 各技術
  • 疾病的各類型
  • 各終端用戶
  • 各國

第8章 亞太地區市場規模與預測

  • 各產品類型
  • 各技術
  • 疾病的各類型
  • 各終端用戶
  • 各國

第9章 南美市場規模與預測

  • 各產品類型
  • 各技術
  • 疾病的各類型
  • 各終端用戶
  • 各國

第10章 中東、非洲市場規模與預測

  • 各產品類型
  • 各技術
  • 疾病的各類型
  • 各終端用戶
  • 各國

第11章 主要國家的市場

  • 美國
  • 加拿大
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 中國
  • 日本
  • 印度

第12章 競爭情形

  • 主要企業的市場佔有率分析
  • 主要企業的產品基準
  • 市場上的策略性的動向
    • 產品核可/銷售
    • 合作/收購/契約
    • 其他動向

第13章 企業簡介

  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Becton, Dickinson and Company
  • General Electric Company
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Siemens AG
  • Grifols S.A.
  • Ortho-Clinical Diagnostics Inc.
  • DiaSorin S.p.A.
  • J. Mitra & Co. Pvt. Ltd.
  • Bio-Techne Corporation
  • Trinity Biotech plc
  • Gesellschaft zur Forschung, Entwicklung und Distribution von Diagnostika im Blutspendewesen mbH (GFE)
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • PerkinElmer Inc.
  • bioMerieux S.A.

第14章 附錄

  • 簡稱
  • 參考資料
  • 相關報告
目錄
Product Code: LS11982

Title:
Blood Screening Market Research Report: By Product Type (Reagents and Kits, Instruments, Software & Services), Technology (NAT, ELISA, Rapid Testing, Western Blotting, Next-Generation Sequencing), Disease Type (HIV/AIDS, Cancer, Diabetes Mellitus, Infectious Diseases, Hypercholesterolemia, Respiratory Diseases), End User (Blood Banks, Diagnostic Centers and Pathology Labs, Hospitals, Clinics, ASCs) - Global Industry Size, Share, Growth and Demand Forecast to 2030.

"According to the World Health Organization (WHO), the number of blood donations has increased manifold in the last few years. The biggest jump in voluntary unpaid donations has been registered in Southeast Asia and the Americas, with the former region recording a donation of 5.9 million units in 2015. Among the countries covered in the WHO article, 78 get almost 90% of the blood from unpaid voluntary people.

With the increasing blood donation activities, the demand for the various products used to test blood for infections is also rising. This is predicted to lead to the growth of the global blood screening market, at a CAGR of 8.1% between 2020 and 2030 (forecast period); the market stood at $2,402.3 million in 2019.

Nucleic Acid Technology (NAT) to Dominate the Market till 2030

Till 2030, the nucleic acid technology (NAT) category would hold the largest share in the blood screening market, as this technology is more sensitive than others, which leads to its heavy usage at blood testing establishments.

During the historical period (2014-2019), the reagents & kits were the highest-revenue-generating division in the blood screening market, as they are used repeatedly during blood screening. Other reasons for this are that a wide array of reagents are easily available and the demand for quick and reliable results regarding the presence of transfusion-transmissible infections (TTIs) in the blood is rising.

The cancer classification is expected to experience the highest CAGR in the blood screening market, of 8.7%, during the forecast period. This is owing to the rising prevalence of cancer and the fact that during treatment, blood is heavily screened for infections, before giving it to patients. According to the WHO, cancer is already the second-leading cause of mortality, leading to approximately 9.6 million deaths annually.

Blood banks dominated the blood screening market in 2019, as a result of the high organ transplant surgery volume, increasing awareness regarding the safety of transfused blood, and surging blood donation activities.

North America was the largest market for blood screening products and services during the historical period, due to the presence of numerous market players, who are introducing a range of new products, and the increasing prevalence of respiratory and infectious diseases. In the coming years, Asia-Pacific (APAC) would witness the fastest blood screening market growth, on account of the surging activities of key players, low labor cost, and increasing incidence of chronic diseases, especially cancer, in the region.

Product Launches are Strongest Strategic Measures in Market

Product launches have been the strongest strategic measure taken by the companies operating in the blood screening market, in order to strengthen their position in the industry.

For instance, Bio-Techne Corporation introduced the QuicKit enzyme-linked immunosorbent assay (ELISA) product line in February 2020. This enhanced product line is designed to help researchers accomplish more without having the blood sample compromised. With this kit, the protein concentration in plasma, serum, and cell supernates can be detected within 90 minutes.

In March 2020, Ortho-Clinical Diagnostics Inc. received the USFDA 510(k) clearance to market its VITROS B.R.A.H.M.S Procalcitonin (PCT) assay to help clinicians identify sepsis and other severe bacterial infections. The assay will be available in the coming weeks on the VITROS 3600 immunodiagnostic system, VITROS 5600 and VITROS XT 7600 integrated systems, and VITROS ECi and ECiQ systems.

Abbott Laboratories, General Electric Company, Bio-Rad Laboratories Inc., Merck KGaA, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Siemens AG, DiaSorin S.p.A, Grifols S.A., Bio-Techne Corporation, J. Mitra & Co. Pvt. Ltd., Ortho-Clinical Diagnostics Inc., Trinity Biotech plc, F. Hoffmann-La Roche Ltd., Gesellschaft zur Forschung, PerkinElmer Inc., Danaher Corporation, Entwicklung und Distribution von Diagnostika im Blutspendewesen mbH (GFE), and bioMerieux SA are the major players in the global blood screening market."

Table of Contents

Chapter 1. Research Background

  • 1.1 Research Objectives
  • 1.2 Market Definition
  • 1.3 Research Scope
    • 1.3.1 Market Segmentation by Product Type
    • 1.3.2 Market Segmentation by Technology
    • 1.3.3 Market Segmentation by Disease Type
    • 1.3.4 Market Segmentation by End User
    • 1.3.5 Market Segmentation by Geography
    • 1.3.6 Analysis Period
    • 1.3.7 Market Data Reporting Unit
  • 1.4 Key Stakeholders

Chapter 2. Research Methodology

  • 2.1 Secondary Research
  • 2.2 Primary Research
    • 2.2.1 Split of Primary Research Information
    • 2.2.2 Breakdown of Primary Research by Industry Participant
    • 2.2.3 Breakdown of Primary Research by Company Type
    • 2.2.4 Breakdown of Primary Research by Company and Designation
  • 2.3 Baseline Methodology
  • 2.4 Market Size Estimation
  • 2.5 KOLs' Sources
  • 2.6 Data Triangulation
  • 2.7 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

  • 4.1 Definition of Market Segments
    • 4.1.1 By Product Type
      • 4.1.1.1 Reagents and kits
        • 4.1.1.1.1 NAT
        • 4.1.1.1.2 ELISA
      • 4.1.1.2 Instruments
        • 4.1.1.2.1 By platform
        • 4.1.1.2.1.1 Automated
        • 4.1.1.2.1.2 Semi-Automated
        • 4.1.1.2.2 By purchase type
        • 4.1.1.2.2.1 Outright purchase
        • 4.1.1.2.2.2 Rental purchase
      • 4.1.1.3 Software and services
    • 4.1.2 By Technology
      • 4.1.2.1 NAT
        • 4.1.2.1.1 TMA
        • 4.1.2.1.2 Real-time PCR
      • 4.1.2.2 ELISA
        • 4.1.2.2.1 CLIA
        • 4.1.2.2.2 FIA
        • 4.1.2.2.3 CIA
      • 4.1.2.3 Rapid testing
      • 4.1.2.4 Western blotting
      • 4.1.2.5 NGS
    • 4.1.3 By Disease Type
      • 4.1.3.1 Cancer
      • 4.1.3.2 Diabetes mellitus
      • 4.1.3.3 Hypercholesterolemia
      • 4.1.3.4 Infectious diseases
      • 4.1.3.5 Respiratory diseases
      • 4.1.3.6 HIV/AIDS
    • 4.1.4 By End User
      • 4.1.4.1 Diagnostic centers and pathology labs
      • 4.1.4.2 Blood banks
      • 4.1.4.3 Hospitals
      • 4.1.4.4 Clinics
      • 4.1.4.5 ASCs
      • 4.1.4.6 Others
  • 4.2 Market Dynamics
    • 4.2.1 Trends
      • 4.2.1.1 Approval and launch of new products
      • 4.2.1.2 Increasing number of collaborations and agreements
    • 4.2.2 Drivers
      • 4.2.2.1 Regulations to ensure safety regarding blood contamination
      • 4.2.2.2 Surging burden chronic diseases
      • 4.2.2.3 Increasing number of blood donors
      • 4.2.2.4 Technological advancements in screening technology
      • 4.2.2.5 Increasing healthcare expenditure
      • 4.2.2.6 Impact analysis of drivers on market forecast
    • 4.2.3 Restraints
      • 4.2.3.1 Challenges in maintaining sufficient safe blood supply
      • 4.2.3.2 Data insecurity of donors' demographic information
      • 4.2.3.3 Cost-ineffectiveness of instruments
      • 4.2.3.4 Impact analysis of restraints on market forecast

Chapter 5. Global Market Size and Forecast

  • 5.1 By Product Type
    • 5.1.1 Reagents and Kits Market, by Type
      • 5.1.1.1 NAT reagents and kits market, by type
      • 5.1.1.2 ELISA reagents and kits market, by type
    • 5.1.2 Instruments Market, by Platform
    • 5.1.3 Instruments Market, by Purchase Type
  • 5.2 By Technology
    • 5.2.1 NAT Technology Market, by Product Type
    • 5.2.2 NAT Technology Market, by Type
    • 5.2.3 ELISA Technology Market, by Product Type
    • 5.2.4 ELISA Technology Market, by Type
    • 5.2.5 Rapid Testing Technology Market, by Product Type
    • 5.2.6 Western Blotting Technology Market, by Product Type
    • 5.2.7 NGS Technology Market, by Product Type
  • 5.3 By Disease Type
  • 5.4 By End User
  • 5.5 By Region

Chapter 6. North America Market Size and Forecast

  • 6.1 By Product Type
    • 6.1.1 Reagents and Kits Market, by Type
      • 6.1.1.1 NAT reagents and kits market, by type
      • 6.1.1.2 ELISA reagents and kits market, by type
    • 6.1.2 Instruments Market, by Platform
    • 6.1.3 Instruments Market, by Purchase Type
  • 6.2 By Technology
    • 6.2.1 NAT Technology Market, by Product Type
    • 6.2.2 NAT Technology Market, by Type
    • 6.2.3 ELISA Technology Market, by Product Type
    • 6.2.4 ELISA TECHNOLOGY MARKET, BY TYPE
    • 6.2.5 Rapid Testing Technology Market, by Product Type
    • 6.2.6 Western Blotting Technology Market, by Product Type
    • 6.2.7 NGS Technology Market, by Product Type
  • 6.3 By Disease Type
  • 6.4 By End User
  • 6.5 By Country

Chapter 7. Europe Market Size and Forecast

  • 7.1 By Product Type
    • 7.1.1 Reagents and Kits Market, by Type
      • 7.1.1.1 NAT reagents and kits market, by type
      • 7.1.1.2 ELISA reagents and kits market, by type
    • 7.1.2 Instruments Market, by Platform
    • 7.1.3 Instruments Market, by Purchase Type
  • 7.2 By Technology
    • 7.2.1 NAT Technology Market, by Product Type
    • 7.2.2 NAT Technology Market, by Type
    • 7.2.3 ELISA Technology Market, by Product Type
    • 7.2.4 ELISA Technology Market, by Type
    • 7.2.5 Rapid Testing Technology Market, by Product Type
    • 7.2.6 Western Blotting Technology Market, by Product Type
    • 7.2.7 NGS Technology Market, by Product Type
  • 7.3 By Disease Type
  • 7.4 By End User
  • 7.5 By Country

Chapter 8. APAC Market Size and Forecast

  • 8.1 By Product Type
    • 8.1.1 Reagents and Kits Market, by Type
      • 8.1.1.1 NAT reagents and kits market, by type
      • 8.1.1.2 ELISA reagents and kits market, by type
    • 8.1.2 Instruments Market, by Platform
    • 8.1.3 Instruments Market, by Purchase Type
  • 8.2 By Technology
    • 8.2.1 NAT Technology Market, by Product Type
    • 8.2.2 NAT Technology Market, by Type
    • 8.2.3 ELISA Technology Market, by Product Type
    • 8.2.4 ELISA Technology Market, by Type
    • 8.2.5 Rapid Testing Technology Market, by Product Type
    • 8.2.6 Western Blotting Technology Market, by Product Type
    • 8.2.7 NGS Technology Market, by Product Type
  • 8.3 By Disease Type
  • 8.4 By End User
  • 8.5 By Country

Chapter 9. LATAM Market Size and Forecast

  • 9.1 By Product Type
    • 9.1.1 Reagents and Kits Market, by Type
      • 9.1.1.1 NAT reagents and kits market, by type
      • 9.1.1.2 ELISA reagents and kits market, by type
    • 9.1.2 Instruments Market, by Platform
    • 9.1.3 Instruments Market, by Purchase Type
  • 9.2 By Technology
    • 9.2.1 NAT Technology Market, by Product Type
    • 9.2.2 NAT Technology Market, by Type
    • 9.2.3 ELISA Technology Market, by Product Type
    • 9.2.4 ELISA Technology Market, by Type
    • 9.2.5 Rapid Testing Technology Market, by Product Type
    • 9.2.6 Western Blotting Technology Market, by Product Type
    • 9.2.7 NGS Technology Market, by Product Type
  • 9.3 By Disease Type
  • 9.4 By End User
  • 9.5 By Country

Chapter 10. MEA Market Size and Forecast

  • 10.1 By Product Type
    • 10.1.1 Reagents and Kits Market, by Type
      • 10.1.1.1 NAT reagents and kits market, by type
      • 10.1.1.2 ELISA reagents and kits market, by type
    • 10.1.2 Instruments Market, by Platform
    • 10.1.3 Instruments Market, by Purchase Type
  • 10.2 By Technology
    • 10.2.1 NAT Technology Market, by Product Type
    • 10.2.2 NAT Technology Market, by Type
    • 10.2.3 ELISA Technology Market, by Product Type
    • 10.2.4 ELISA Technology Market, by Type
    • 10.2.5 Rapid Testing Technology Market, by Product Type
    • 10.2.6 Western Blotting Technology Market, by Product Type
    • 10.2.7 NGS Technology Market, by Product Type
  • 10.3 By Disease Type
  • 10.4 By End User
  • 10.5 By Country

Chapter 11. Major Markets: Segment Analysis

  • 11.1 U.S.
    • 11.1.1 U.S. Blood Screening Market, by Product Type
    • 11.1.2 U.S. Blood Screening Market, by Technology
  • 11.2 Canada
    • 11.2.1 Canada Blood Screening Market, by Product Type
    • 11.2.2 Canada Blood Screening Market, by Technology
  • 11.3 Germany
    • 11.3.1 Germany Blood Screening Market, by Product Type
    • 11.3.2 Germany Blood Screening Market, by Technology
  • 11.4 France
    • 11.4.1 France Blood Screening Market, by Product Type
    • 11.4.2 France Blood Screening Market, by Technology
  • 11.5 U.K.
    • 11.5.1 U.K. Blood Screening Market, by Product Type
    • 11.5.2 U.K. Blood Screening Market, by Technology
  • 11.6 Italy
    • 11.6.1 Italy Blood Screening Market, by Product Type
    • 11.6.2 Italy Blood Screening Market, by Technology
  • 11.7 Spain
    • 11.7.1 Spain Blood Screening Market, by Product Type
    • 11.7.2 Spain Blood Screening Market, by Technology
  • 11.8 China
    • 11.8.1 China Blood Screening Market, by Product Type
    • 11.8.2 China Blood Screening Market, by Technology
  • 11.9 Japan
    • 11.9.1 Japan Blood Screening Market, by Product Type
    • 11.9.2 Japan Blood Screening Market, by Technology
  • 11.10 India
    • 11.10.1 India Blood Screening Market, by Product Type
    • 11.10.2 India Blood Screening Market, by Technology

Chapter 12. Competitive Landscape

  • 12.1 Market Share Analysis of Key Players
  • 12.2 Products Benchmarking of Key Players
  • 12.3 Strategic Developments in the Market
    • 12.3.1 Product Approvals/Launches
    • 12.3.2 Collaborations/Acquisitions/Agreements
    • 12.3.3 Other Developments

Chapter 13. Company Profiles

  • 13.1 Abbott Laboratories
    • 13.1.1 Business Overview
    • 13.1.2 Product and Service Offerings
    • 13.1.3 Key Financial Summary
  • 13.2 Bio-Rad Laboratories Inc.
    • 13.2.1 Business Overview
    • 13.2.2 Product and Service Offerings
    • 13.2.3 Key Financial Summary
  • 13.3 Becton, Dickinson and Company
    • 13.3.1 Business Overview
    • 13.3.2 Product and Service Offerings
    • 13.3.3 Key Financial Summary
  • 13.4 General Electric Company
    • 13.4.1 Business Overview
    • 13.4.2 Product and Service Offerings
    • 13.4.3 Key Financial Summary
  • 13.5 Thermo Fisher Scientific Inc.
    • 13.5.1 Business Overview
    • 13.5.2 Product and Service Offerings
    • 13.5.3 Key Financial Summary
  • 13.6 Merck KGaA
    • 13.6.1 Business Overview
    • 13.6.2 Product and Service Offerings
    • 13.6.3 Key Financial Summary
  • 13.7 Siemens AG
    • 13.7.1 Business Overview
    • 13.7.2 Product and Service Offerings
    • 13.7.3 Key Financial Summary
  • 13.8 Grifols S.A.
    • 13.8.1 Business Overview
    • 13.8.2 Product and Service Offerings
    • 13.8.3 Key Financial Summary
  • 13.9 Ortho-Clinical Diagnostics Inc.
    • 13.9.1 Business Overview
    • 13.9.2 Product and Service Offerings
  • 13.10 DiaSorin S.p.A.
    • 13.10.1 Business Overview
    • 13.10.2 Product and Service Offerings
    • 13.10.3 Key Financial Summary
  • 13.11 J. Mitra & Co. Pvt. Ltd.
    • 13.11.1 Business Overview
    • 13.11.2 Product and Service Offerings
  • 13.12 Bio-Techne Corporation
    • 13.12.1 Business Overview
    • 13.12.2 Product and Service Offerings
    • 13.12.3 Key Financial Summary
  • 13.13 Trinity Biotech plc
    • 13.13.1 Business Overview
    • 13.13.2 Product and Service Offerings
    • 13.13.3 Key Financial Summary
  • 13.14 Gesellschaft zur Forschung, Entwicklung und Distribution von Diagnostika im Blutspendewesen mbH (GFE)
    • 13.14.1 Business Overview
    • 13.14.2 Product and Service Offerings
  • 13.15 Danaher Corporation
    • 13.15.1 Business Overview
    • 13.15.2 Product and Service Offerings
    • 13.15.3 Key Financial Summary
  • 13.16 F. Hoffmann-La Roche Ltd.
    • 13.16.1 Business Overview
    • 13.16.2 Product and Service Offerings
    • 13.16.3 Key Financial Summary
  • 13.17 PerkinElmer Inc.
    • 13.17.1 Business Overview
    • 13.17.2 Product and Service Offerings
    • 13.17.3 Key Financial Summary
  • 13.18 bioMerieux S.A.
    • 13.18.1 Business Overview
    • 13.18.2 Product and Service Offerings
    • 13.18.3 Key Financial Summary

Chapter 14. Appendix

  • 14.1 Abbreviations
  • 14.2 Sources and References
  • 14.3 Related Reports

LIST OF TABLES

  • TABLE 1 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 1 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 2 GLOBAL BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 3 GLOBAL BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 4 GLOBAL BLOOD SCREENING REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 5 GLOBAL BLOOD SCREENING REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 6 GLOBAL NAT REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 7 GLOBAL NAT REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 8 GLOBAL ELISA REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 9 GLOBAL ELISA REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 10 GLOBAL BLOOD SCREENING INSTRUMENTS MARKET, BY PLATFORM, $M (2014-2019)
  • TABLE 11 GLOBAL BLOOD SCREENING INSTRUMENTS MARKET, BY PLATFORM, $M (2020-2030)
  • TABLE 12 GLOBAL BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, $M (2014-2019)
  • TABLE 13 GLOBAL BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, $M (2020-2030)
  • TABLE 14 GLOBAL BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 15 GLOBAL BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 16 GLOBAL NAT TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 17 GLOBAL NAT TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 18 GLOBAL NAT TECHNOLOGY MARKET, BY TYPE, $M (2014-2019)
  • TABLE 19 GLOBAL NAT TECHNOLOGY MARKET, BY TYPE, $M (2020-2030)
  • TABLE 20 GLOBAL ELISA TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 21 GLOBAL ELISA TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 22 GLOBAL ELISA TECHNOLOGY MARKET, BY TYPE, $M (2014-2019)
  • TABLE 23 GLOBAL ELISA TECHNOLOGY MARKET, BY TYPE, $M (2020-2030)
  • TABLE 24 GLOBAL RAPID TESTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 25 GLOBAL RAPID TESTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 26 GLOBAL WESTERN BLOTTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 27 GLOBAL WESTERN BLOTTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 28 GLOBAL NGS TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 29 GLOBAL NGS TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 30 GLOBAL BLOOD SCREENING MARKET, BY DISEASE TYPE, $M (2014-2019)
  • TABLE 31 GLOBAL BLOOD SCREENING MARKET, BY DISEASE TYPE, $M (2020-2030)
  • TABLE 32 GLOBAL BLOOD SCREENING MARKET, BY END USER, $M (2014-2019)
  • TABLE 33 GLOBAL BLOOD SCREENING MARKET, BY END USER, $M (2020-2030)
  • TABLE 34 GLOBAL BLOOD SCREENING MARKET, BY REGION, $M (2014-2019)
  • TABLE 35 GLOBAL BLOOD SCREENING MARKET, BY REGION, $M (2020-2030)
  • TABLE 36 NORTH AMERICA BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 37 NORTH AMERICA BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 38 NORTH AMERICA BLOOD SCREENING REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 39 NORTH AMERICA BLOOD SCREENING REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 40 NORTH AMERICA NAT REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 41 NORTH AMERICA NAT REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 42 NORTH AMERICA ELISA REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 43 NORTH AMERICA ELISA REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 44 NORTH AMERICA BLOOD SCREENING INSTRUMENTS MARKET, BY PLATFORM, $M (2014-2019)
  • TABLE 45 NORTH AMERICA BLOOD SCREENING INSTRUMENTS MARKET, BY PLATFORM, $M (2020-2030)
  • TABLE 46 NORTH AMERICA BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, $M (2014-2019)
  • TABLE 47 NORTH AMERICA BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, $M (2020-2030)
  • TABLE 48 NORTH AMERICA BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 49 NORTH AMERICA BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 50 NORTH AMERICA NAT TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 51 NORTH AMERICA NAT TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 52 NORTH AMERICA NAT TECHNOLOGY MARKET, BY TYPE, $M (2014-2019)
  • TABLE 53 NORTH AMERICA NAT TECHNOLOGY MARKET, BY TYPE, $M (2020-2030)
  • TABLE 54 NORTH AMERICA ELISA TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 55 NORTH AMERICA ELISA TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 56 NORTH AMERICA ELISA TECHNOLOGY MARKET, BY TYPE, $M (2014-2019)
  • TABLE 57 NORTH AMERICA TECHNOLOGY MARKET, BY ELISA, $M (2020-2030)
  • TABLE 58 NORTH AMERICA RAPID TESTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 59 NORTH AMERICA RAPID TESTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 60 NORTH AMERICA WESTERN BLOTTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 61 NORTH AMERICA WESTERN BLOTTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 62 NORTH AMERICA NGS TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 63 NORTH AMERICA NGS TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 64 NORTH AMERICA BLOOD SCREENING MARKET, BY DISEASE TYPE, $M (2014-2019)
  • TABLE 65 NORTH AMERICA BLOOD SCREENING MARKET, BY DISEASE TYPE, $M (2020-2030)
  • TABLE 66 NORTH AMERICA BLOOD SCREENING MARKET, BY END USER, $M (2014-2019)
  • TABLE 67 NORTH AMERICA BLOOD SCREENING MARKET, BY END USER, $M (2020-2030)
  • TABLE 68 NORTH AMERICA BLOOD SCREENING MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 69 NORTH AMERICA BLOOD SCREENING MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 70 EUROPE BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 71 EUROPE BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 72 EUROPE BLOOD SCREENING REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 73 EUROPE BLOOD SCREENING REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 74 EUROPE NAT REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 75 EUROPE NAT REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 76 EUROPE ELISA REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 77 EUROPE ELISA REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 78 EUROPE BLOOD SCREENING INSTRUMENTS MARKET, BY PLATFORM, $M (2014-2019)
  • TABLE 79 EUROPE BLOOD SCREENING INSTRUMENTS MARKET, BY PLATFORM, $M (2020-2030)
  • TABLE 80 EUROPE BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, $M (2014-2019)
  • TABLE 81 EUROPE BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, $M (2020-2030)
  • TABLE 82 EUROPE BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 83 EUROPE BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 84 EUROPE NAT TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 85 EUROPE NAT TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 86 EUROPE NAT TECHNOLOGY MARKET, BY TYPE, $M (2014-2019)
  • TABLE 87 EUROPE NAT TECHNOLOGY MARKET, BY TYPE, $M (2020-2030)
  • TABLE 88 EUROPE ELISA TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 89 EUROPE ELISA TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 90 EUROPE ELISA TECHNOLOGY MARKET, BY TYPE, $M (2014-2019)
  • TABLE 91 EUROPE ELISA TECHNOLOGY MARKET, BY TYPE, $M (2020-2030)
  • TABLE 92 EUROPE RAPID TESTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 93 EUROPE RAPID TESTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 94 EUROPE WESTERN BLOTTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 95 EUROPE WESTERN BLOTTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 96 EUROPE NGS TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 97 EUROPE NGS TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 98 EUROPE BLOOD SCREENING MARKET, BY DISEASE TYPE, $M (2014-2019)
  • TABLE 99 EUROPE BLOOD SCREENING MARKET, BY DISEASE TYPE, $M (2020-2030)
  • TABLE 100 EUROPE BLOOD SCREENING MARKET, BY END USER, $M (2014-2019)
  • TABLE 101 EUROPE BLOOD SCREENING MARKET, BY END USER, $M (2020-2030)
  • TABLE 102 EUROPE BLOOD SCREENING MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 103 EUROPE BLOOD SCREENING MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 104 APAC BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 105 APAC BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 106 APAC BLOOD SCREENING REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 107 APAC BLOOD SCREENING REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 108 APAC NAT REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 109 APAC NAT REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 110 APAC ELISA REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 111 APAC ELISA REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 112 APAC BLOOD SCREENING INSTRUMENTS MARKET, BY PLATFORM, $M (2014-2019)
  • TABLE 113 APAC BLOOD SCREENING INSTRUMENTS MARKET, BY PLATFORM, $M (2020-2030)
  • TABLE 114 APAC BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, $M (2014-2019)
  • TABLE 115 APAC BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, $M (2020-2030)
  • TABLE 116 APAC BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 117 APAC BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 118 APAC NAT TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 119 APAC NAT TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 120 APAC NAT TECHNOLOGY MARKET, BY TYPE, $M (2014-2019)
  • TABLE 121 APAC NAT TECHNOLOGY MARKET, BY TYPE, $M (2020-2030)
  • TABLE 122 APAC ELISA TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 123 APAC ELISA TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 124 APAC ELISA TECHNOLOGY MARKET, BY TYPE, $M (2014-2019)
  • TABLE 125 APAC ELISA TECHNOLOGY MARKET, BY TYPE, $M (2020-2030)
  • TABLE 126 APAC RAPID TESTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 127 APAC RAPID TESTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 128 APAC WESTERN BLOTTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 129 APAC WESTERN BLOTTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 130 APAC NGS TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 131 APAC NGS TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 132 APAC BLOOD SCREENING MARKET, BY DISEASE TYPE, $M (2014-2019)
  • TABLE 133 APAC BLOOD SCREENING MARKET, BY DISEASE TYPE, $M (2020-2030)
  • TABLE 134 APAC BLOOD SCREENING MARKET, BY END USER, $M (2014-2019)
  • TABLE 135 APAC BLOOD SCREENING MARKET, BY END USER, $M (2020-2030)
  • TABLE 136 APAC BLOOD SCREENING MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 137 APAC BLOOD SCREENING MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 138 LATAM BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 139 LATAM BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 140 LATAM BLOOD SCREENING REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 141 LATAM BLOOD SCREENING REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 142 LATAM NAT REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 143 LATAM NAT REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 144 LATAM ELISA REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 145 LATAM ELISA REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 146 LATAM BLOOD SCREENING INSTRUMENTS MARKET, BY PLATFORM, $M (2014-2019)
  • TABLE 147 LATAM BLOOD SCREENING INSTRUMENTS MARKET, BY PLATFORM, $M (2020-2030)
  • TABLE 148 LATAM BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, $M (2014-2019)
  • TABLE 149 LATAM BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, $M (2020-2030)
  • TABLE 150 LATAM BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 151 LATAM BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 152 LATAM NAT TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 153 LATAM NAT TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 154 LATAM NAT TECHNOLOGY MARKET, BY TYPE, $M (2014-2019)
  • TABLE 155 LATAM NAT TECHNOLOGY MARKET, BY TYPE, $M (2020-2030)
  • TABLE 156 LATAM ELISA TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 157 LATAM ELISA TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 158 LATAM ELISA TECHNOLOGY MARKET, BY TYPE, $M (2014-2019)
  • TABLE 159 LATAM ELISA TECHNOLOGY MARKET, BY TYPE, $M (2020-2030)
  • TABLE 160 LATAM RAPID TESTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 161 LATAM RAPID TESTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 162 LATAM WESTERN BLOTTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 163 LATAM WESTERN BLOTTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 164 LATAM NGS TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 165 LATAM NGS TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 166 LATAM BLOOD SCREENING MARKET, BY DISEASE TYPE, $M (2014-2019)
  • TABLE 167 LATAM BLOOD SCREENING MARKET, BY DISEASE TYPE, $M (2020-2030)
  • TABLE 168 LATAM BLOOD SCREENING MARKET, BY END USER, $M (2014-2019)
  • TABLE 169 LATAM BLOOD SCREENING MARKET, BY END USER, $M (2020-2030)
  • TABLE 170 LATAM BLOOD SCREENING MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 171 LATAM BLOOD SCREENING MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 172 MEA BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 173 MEA BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 174 MEA BLOOD SCREENING REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 175 MEA BLOOD SCREENING REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 176 MEA NAT REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 177 MEA NAT REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 178 MEA ELISA REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 179 MEA ELISA REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 180 MEA BLOOD SCREENING INSTRUMENTS MARKET, BY PLATFORM, $M (2014-2019)
  • TABLE 181 MEA BLOOD SCREENING INSTRUMENTS MARKET, BY PLATFORM, $M (2020-2030)
  • TABLE 182 MEA BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, $M (2014-2019)
  • TABLE 183 MEA BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, $M (2020-2030)
  • TABLE 184 MEA BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 185 MEA BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 186 MEA NAT TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 187 MEA NAT TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 188 MEA NAT TECHNOLOGY MARKET, BY TYPE, $M (2014-2019)
  • TABLE 189 MEA NAT TECHNOLOGY MARKET, BY TYPE, $M (2020-2030)
  • TABLE 190 MEA ELISA TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 191 MEA ELISA TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 192 MEA ELISA TECHNOLOGY MARKET, BY TYPE, $M (2014-2019)
  • TABLE 193 MEA ELISA TECHNOLOGY MARKET, BY TYPE, $M (2020-2030)
  • TABLE 194 MEA RAPID TESTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 195 MEA RAPID TESTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 196 MEA WESTERN BLOTTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 197 MEA WESTERN BLOTTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 198 MEA NGS TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 199 MEA NGS TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 200 MEA BLOOD SCREENING MARKET, BY DISEASE TYPE, $M (2014-2019)
  • TABLE 201 MEA BLOOD SCREENING MARKET, BY DISEASE TYPE, $M (2020-2030)
  • TABLE 202 MEA BLOOD SCREENING MARKET, BY END USER, $M (2014-2019)
  • TABLE 203 MEA BLOOD SCREENING MARKET, BY END USER, $M (2020-2030)
  • TABLE 204 MEA BLOOD SCREENING MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 205 MEA BLOOD SCREENING MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 206 U.S. BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 207 U.S. BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 208 U.S. BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 209 U.S. BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 210 CANADA BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 211 CANADA BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 212 CANADA BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 213 CANADA BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 214 GERMANY BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 215 GERMANY BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 216 GERMANY BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 217 GERMANY BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 218 FRANCE BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 219 FRANCE BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 220 FRANCE BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 221 FRANCE BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 222 U.K. BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 223 U.K. BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 224 U.K. BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 225 U.K. BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 226 ITALY BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 227 ITALY BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 228 ITALY BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 229 ITALY BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 230 SPAIN BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 231 SPAIN BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 232 SPAIN BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 233 SPAIN BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 234 CHINA BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 235 CHINA BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 236 CHINA BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 237 CHINA BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 238 JAPAN BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 239 JAPAN BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 240 JAPAN BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 241 JAPAN BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 242 INDIA BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
  • TABLE 243 INDIA BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
  • TABLE 244 INDIA BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 245 INDIA BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 246 PRODUCT BENCHMARKING OF KEY PLAYERS
  • TABLE 247 ABBOTT LABORATORIES - AT A GLANCE
  • TABLE 248 ABBOTT LABORATORIES - KEY FINANCIAL SUMMARY
  • TABLE 249 BIO-RAD LABORATORIES INC. - AT A GLANCE
  • TABLE 250 BIO-RAD LABORATORIES INC. - KEY FINANCIAL SUMMARY
  • TABLE 251 BECTON, DICKINSON AND COMPANY - AT A GLANCE
  • TABLE 252 BECTON, DICKINSON AND COMPANY - KEY FINANCIAL SUMMARY
  • TABLE 253 GENERAL ELECTRIC COMPANY - AT A GLANCE
  • TABLE 254 GENERAL ELECTRIC COMPANY - KEY FINANCIAL SUMMARY
  • TABLE 255 THERMO FISHER SCIENTIFIC INC. - AT A GLANCE
  • TABLE 256 THERMO FISHER SCIENTIFIC INC. - KEY FINANCIAL SUMMARY
  • TABLE 257 MERCK KGAA - AT A GLANCE
  • TABLE 258 MERCK KGAA - KEY FINANCIAL SUMMARY
  • TABLE 259 SIEMENS AG - AT A GLANCE
  • TABLE 260 SIEMENS AG - KEY FINANCIAL SUMMARY
  • TABLE 261 GRIFOLS S.A. - AT A GLANCE
  • TABLE 262 GRIFOLS S.A. - KEY FINANCIAL SUMMARY
  • TABLE 263 ORTHO-CLINICAL DIAGNOSTICS INC. - AT A GLANCE
  • TABLE 264 ORTHO-CLINICAL DIAGNOSTICS INC. - PRODUCT AND SERVICE OFFERINGS
  • TABLE 265 DIASORIN S.P.A. - AT A GLANCE
  • TABLE 266 DIASORIN S.P.A. - PRODUCT AND SERVICE OFFERINGS
  • TABLE 267 DIASORIN S.P.A. - KEY FINANCIAL SUMMARY
  • TABLE 268 J. MITRA & CO. PVT. LTD. - AT A GLANCE
  • TABLE 269 J. MITRA & CO. PVT. LTD. - PRODUCT AND SERVICE OFFERINGS
  • TABLE 270 BIO-TECHNE CORPORATION - AT A GLANCE
  • TABLE 271 BIO-TECHNE CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 272 TRINITY BIOTECH PLC - AT A GLANCE
  • TABLE 273 TRINITY BIOTECH PLC. - KEY FINANCIAL SUMMARY
  • TABLE 274 GFE - AT A GLANCE
  • TABLE 275 DANAHER CORPORATION - AT A GLANCE
  • TABLE 276 DANAHER CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 277 F. HOFFMANN-LA ROCHE LTD. - AT A GLANCE
  • TABLE 278 F. HOFFMANN-LA ROCHE LTD. - KEY FINANCIAL SUMMARY
  • TABLE 279 PERKINELMER INC. - AT A GLANCE
  • TABLE 280 PERKINELMER INC. - KEY FINANCIAL SUMMARY
  • TABLE 281 BIOMERIEUX S.A. - AT A GLANCE
  • TABLE 282 BIOMERIEUX S.A. - KEY FINANCIAL SUMMARY